Methadone's effects on pentylenetetrazole‐induced seizure threshold in mice: NMDA/opioid receptors and nitric oxide signaling
- 7 April 2019
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1449 (1) , 25-35
Abstract
Methadone is a synthetic opioid used to treat opiate withdrawal and addiction. Studies have demonstrated the impact of methadone on seizure susceptibility. This study investigated the modulatory impacts of acute and subchronic (three times daily for 5 days) intraperitoneal methadone treatment on pentylenetetrazole‐induced clonic seizure threshold (CST) in mice, as well as the involvement of the nitric oxide, N‐methyl‐d‐aspartate (NMDA), and µ‐opioid pathways. Acute administration of different doses of methadone (0.1, 0.3, 1, and 3 mg/kg) 45 min before CST significantly decreased the seizure threshold. Additionally, pretreatment with noneffective doses of an opioid receptor antagonist (naltrexone) and NMDA receptor antagonists (ketamine and MK‐801) inhibited methadone's proconvulsive activity in the acute phase, while l‐NAME (a nonspecific nitric oxide synthase (NOS) inhibitor) did not affect that activity. In the subchronic phase, methadone (3 mg/kg) demonstrated an anticonvulsive effect. Although subchronic pretreatment with noneffective doses of l‐NAME and 7‐nitroindazole (a specific neuronal NOS inhibitor) reversed methadone's anticonvulsive activity, aminoguanidine (a specific inducible NOS inhibitor), naltrexone, MK‐801, and ketamine did not change methadone's anticonvulsive characteristic. Our results suggest that NMDA and µ‐opioid receptors may be involved in methadone's proconvulsive activity in the acute phase, while methadone's anticonvulsive activity may be modulated by neuronal NOS in the subchronic phase.Keywords
Funding Information
- Iran National Science Foundation
- Tehran University of Medical Sciences and Health Services (96‐02‐30‐35215, 96002757)
This publication has 56 references indexed in Scilit:
- The mu-opioid receptor-selective peptide antagonists, antanal-1 and antanal-2, produce anticonvulsant effects in miceProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2012
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Molecular basis of NMDA receptor functional diversityEuropean Journal of Neuroscience, 2011
- In the rat maximal dentate activation model of partial complex epilepsy, the anticonvulsant activity of levetiracetam is modulated by nitric oxide-active drugsJournal of Neural Transmission, 2009
- Cingulate NMDA NR2B receptors contribute to morphine-induced analgesic toleranceMolecular Brain, 2008
- Ultra-low dose naltrexone potentiates the anticonvulsant effect of low dose morphine on clonic seizuresNeuroscience, 2004
- Increased μ-opioid receptor labeling is found on inner molecular layer terminals of the dentate gyrus following seizures☆☆Supported by NIH Grants DA08259 (T.M.), NS41490 (J.P.), and HL18974 and a grant from the Epilepsy Foundation (S.E.). P.S. Skyers was supported, in part, from the Avon Summer Research Program.Experimental Neurology, 2003
- Quantification of opiate receptors in two patients with mesiobasal temporal lobe epilepsy, before and after selective amygdalo- hippocampectomy, using positron emission tomographyEpilepsy Research, 1994
- Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneuronsNeuron, 1992
- Neonatal seizures associated with narcotic withdrawalThe Journal of Pediatrics, 1977